Vuno Inc.

A338220

KR7338220007

IT Services & Consulting

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
28,400 ^KRW	-.--%		+0.18%	-32.38%

Mar. 26	Vuno Inc. announced that it has received KRW 10.4 billion in funding	CI
Mar. 21	Vuno Inc. announced that it expects to receive KRW 10.4 billion in funding	CI

Vuno Inc. announced that it has received KRW 3 billion in funding from DongKoo Bio&Pharma Co., Ltd.

May 18, 2020

Vuno Inc. announced that it has entered into a memorandum of understanding with DongKoo Bio&Pharma Co., Ltd. (KOSDAQ:A006620) and received KRW 3,000,000,000 in a round of funding on May 19, 2020. The company is pushing for an initial public offering within 2020.

Latest news about Vuno Inc.

Vuno Inc. announced that it has received KRW 10.4 billion in funding	Mar. 25	CI
Vuno Inc. announced that it expects to receive KRW 10.4 billion in funding	Mar. 20	CI
Vuno Inc. Secures FDA 510(K) Clearance for Vuno Med-Deepbrain	23-10-23	CI
Vuno Secures US FDA Approval for AI-Based Brain Imaging Analysis Medical Device	23-10-11	MT
An unknown buyer agreed to acquire 2.94% stake in Puzzle AI Co., Ltd. for KRW 2.5 billion.	23-09-20	CI
VUNO Inc.'s First AI-Based Prospective Study Results Published in Critical Care	23-09-18	CI
Vuno Inc.(KOSDAQ:A338220) added to S&P Global BMI Index	23-09-18	CI
Vuno Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Vuno Inc. announced that it has received KRW 9.999978514 billion in funding	22-12-07	CI
Vuno Inc. announced that it expects to receive KRW 9.999978514 billion in funding	22-11-29	CI
Vuno Inc. announced that it has received KRW 5 billion in funding	22-11-01	CI
Vuno Inc. announced that it expects to receive KRW 5 billion in funding	22-10-31	CI
Vuno Inc.(KOSDAQ:A338220) dropped from S&P Global BMI Index	22-09-19	CI
3,818,929 Common Stock of Vuno Inc. are subject to a Lock-Up Agreement Ending on 26-FEB-2022.	22-02-25	CI
Korean Ministry of Food and Drug Safety Designates the VUNO Inc.'s Artificial Intelligence-Based Electrocardiogram Analysis Software Vuno Med?-Deepecg? as the Ministry's 16th Breakthrough Device	21-11-02	CI
VUNO Inc. Signs Another Deal with Samsung Electronics to Incorporate AI-Assisted Solutions into Samsung's Premium Ceiling Type Digital Radiography System	21-10-05	CI
Vuno Inc.(KOSDAQ:A338220) added to S&P Global BMI Index	21-09-20	CI
738,000 Common Stock of Vuno Inc. are subject to a Lock-Up Agreement Ending on 27-AUG-2021.	21-08-26	CI
Vuno Inc. Received Regulatory Approval from the Ministry of Food and Drug Safety for its VUNO Med®–DeepCARS™	21-08-24	CI
VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung's Premium Mobile X-ray System	21-06-30	CI
54,000 Common Stock of Vuno Inc. are subject to a Lock-Up Agreement Ending on 27-MAY-2021.	21-05-26	CI
3,818,929 Common Stock of Vuno Inc. are subject to a Lock-Up Agreement Ending on 29-MAR-2021.	21-03-28	CI
Vuno Inc. has completed an IPO in the amount of KRW 37.8 billion.	21-02-22	CI
Vuno Inc. has filed an IPO.	20-07-28	CI
Vuno Inc. announced that it has received KRW 3 billion in funding from DongKoo Bio&Pharma Co., Ltd.	20-05-18	CI

Chart Vuno Inc.

Duration

Period

More charts

Company Profile

Vuno Inc is a Korea-based company primarily engaged in the development of medical diagnostic, predictive technologies and solutions based on artificial intelligence (AI) technology.The Company develops and manufactures medical imaging products that assist with medical image-based diagnosis such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and funduscopy; pathology products that assist in the detection of digital scanners, microscopy-based cell quantification and tumor cells; biosignal products that assist and predict diagnosis based on time-series biosignal data such as vital signs and electrocardiogram; medical voice products that automatically create medical charts based on voice recognition. In addition, the Company sells an embolic material product, Nexpear. The Company sells its products in domestic and overseas markets such as Japan, Europe, and the United States.

Sector

IT Services & Consulting

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Vuno Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

28,400 KRW

Average target price

45,000 KRW

Spread / Average Target

+58.45%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Machine Learning & Artificial Intelligence (AI) Services

	1st Jan change	Capi.
VUNO INC.	-32.38%	281M
PRESIGHT AI HOLDING PLC	+19.35%	4.14B
BEIJING FOURTH PARADIGM TECHNOLOGY CO., LTD.	+1.00%	3.02B
CLOUDWALK TECHNOLOGY CO., LTD.	-27.22%	1.76B
BAIRONG INC.	-27.29%	592M
SELVAS AI INC.	-15.47%	324M
EXAWIZARDS INC.	+15.03%	233M
SALTLUX INC.	-8.08%	214M
ALMAWAVE S.P.A.	+6.52%	140M
VERITONE, INC.	+79.01%	123M

Machine Learning & Artificial Intelligence (AI) Services

Vuno Inc.

Equities

A338220

KR7338220007

IT Services & Consulting

Vuno Inc. announced that it has received KRW 3 billion in funding from DongKoo Bio&Pharma Co., Ltd.

Latest news about Vuno Inc.

Chart Vuno Inc.

Company Profile

Income Statement Evolution

Ratings for Vuno Inc.

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Machine Learning & Artificial Intelligence (AI) Services